Therapeutic monoclonal antibody (TMA) based therapies for cancer have advanced
significantly over the past two decades both in their molecular sophistication and clinical …

Poor proteolytic resistance is an urgent problem to be solved in the clinical application of
antimicrobial peptides (AMPs), yet common solutions, such as complicated chemical …

Highlights•Review of the present status of the development of antimicrobial peptides
(AMPs).•Recent advances in designing new anti-infective agents with enhanced …

Production of peptides with various effects from proteins of different sources continues to
receive academic attention. Researchers of different disciplines are putting increasing efforts …

There is a growing awareness that complement plays an integral role in human physiology
and disease, transcending its traditional perception as an accessory system for pathogen …

Myostatin (MSTN) is a well-reported negative regulator of muscle growth and a member of
the transforming growth factor (TGF) family. MSTN has important functions in skeletal muscle …

Background In the past, many methods have been developed for peptide tertiary structure
prediction but they are limited to peptides having natural amino acids. This study describes a …

The surface of a cell represents a collection of macromolecules, which provides the cell with
a unique cellular landscape specific to the type and state of the cell. Ligands that …

In this era of multi-drug resistance (MDR), antimicrobial peptides (AMPs) are one of the most
promising classes of potential drug candidates to combat communicable as well as …

Breast cancer, with around 2 million new cases in 2019, is the second most common cancer
worldwide and the second leading cause of cancer death among females. The aim of this …